These results indicate that MNX1, MNX1-AS1, and MNX1-AS2 are expressed at a higher level in adenocarcinomas and seminomas, compared to squamous and non-seminoma tumours, and that their discriminative power is visualisable using clustering methods. Here, MNX1 is linked to neoplasm.